Take action to tell Congress a 9 percent five-year survival rate is unacceptable and lifesaving research cannot wait.
If you take action and have not already registered, you will receive periodic updates and communications from Pancreatic Cancer Action Network.
Now is the time to build on the momentum and invest in lifesaving cancer research
Dear [Decision Maker],
As your constituent and someone who is committed to improving the statistics for current and future pancreatic cancer patients, I wanted to let you know that the five-year survival rate for pancreatic cancer patients remains at 9 percent. This news comes from the American Cancer Society's 2018 Cancer Facts & Figures report released on January 4, which highlighted pancreatic cancer prevalence and the toll the disease is expected to take in the coming year.
The past three years saw an increase in the five-year survival rate, but the fact that it remained stagnant this year reflects much-needed progress to improve outcomes for patients facing this disease.Pancreatic cancer remains the deadliest major cancer and the third leading cause of cancer-related death in the United States, with no early detection methods and few treatment options.A strong investment in federal research funding translates to better treatment options and outcomes for patients. Pancreatic cancer is an important example of why cancer research funding must continue to be one of our nation's top funding priorities and why there needs to be predictable and sustainable increases for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).
I ask you to pass a FY2018 funding package that includes a $2 billion increase for the NIH. I also urge you and your colleagues to reach a bipartisan agreement to lift the caps on non-defense discretionary spending imposed by the Budget Control Act of 2011.I am committed to doing my part for the 55,440 Americans that will be diagnosed with pancreatic cancer this year. And I am counting on you to continue to invest in lifesaving cancer research because pancreatic cancer patients cannot wait.
Sincerely,[Your Name] [Your Address] [City, State ZIP][Your Email]